CN102475633A - 毛发生长促进剂 - Google Patents
毛发生长促进剂 Download PDFInfo
- Publication number
- CN102475633A CN102475633A CN2010105572969A CN201010557296A CN102475633A CN 102475633 A CN102475633 A CN 102475633A CN 2010105572969 A CN2010105572969 A CN 2010105572969A CN 201010557296 A CN201010557296 A CN 201010557296A CN 102475633 A CN102475633 A CN 102475633A
- Authority
- CN
- China
- Prior art keywords
- hair
- growth promoter
- adenine
- hair growth
- liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000003779 hair growth Effects 0.000 title claims abstract description 47
- 239000007952 growth promoter Substances 0.000 title claims abstract description 38
- 210000004209 hair Anatomy 0.000 claims abstract description 54
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 claims abstract description 37
- 229930024421 Adenine Natural products 0.000 claims abstract description 22
- 229960000643 adenine Drugs 0.000 claims abstract description 22
- 239000000203 mixture Substances 0.000 claims abstract description 21
- 239000006210 lotion Substances 0.000 claims abstract description 19
- 239000013543 active substance Substances 0.000 claims abstract description 14
- 210000004709 eyebrow Anatomy 0.000 claims abstract description 14
- 239000002453 shampoo Substances 0.000 claims abstract description 12
- 239000002904 solvent Substances 0.000 claims abstract description 5
- 239000000314 lubricant Substances 0.000 claims abstract description 4
- 239000002562 thickening agent Substances 0.000 claims abstract description 4
- 239000007788 liquid Substances 0.000 claims description 31
- 239000002537 cosmetic Substances 0.000 claims description 21
- 210000000720 eyelash Anatomy 0.000 claims description 17
- 210000003128 head Anatomy 0.000 claims description 12
- 208000004396 mastitis Diseases 0.000 claims description 11
- 238000007493 shaping process Methods 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 3
- 239000000080 wetting agent Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 16
- 201000004384 Alopecia Diseases 0.000 abstract description 10
- 231100000360 alopecia Toxicity 0.000 abstract description 10
- 238000004140 cleaning Methods 0.000 abstract description 7
- 230000001737 promoting effect Effects 0.000 abstract description 5
- 239000003581 cosmetic carrier Substances 0.000 abstract 2
- 206010048462 Growth of eyelashes Diseases 0.000 abstract 1
- 230000003750 conditioning effect Effects 0.000 abstract 1
- 239000000499 gel Substances 0.000 abstract 1
- 239000008266 hair spray Substances 0.000 abstract 1
- 239000003906 humectant Substances 0.000 abstract 1
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 22
- 229960003632 minoxidil Drugs 0.000 description 20
- 238000012360 testing method Methods 0.000 description 15
- 239000000839 emulsion Substances 0.000 description 10
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- MKPCNMXYTMQZBE-UHFFFAOYSA-N 7h-purin-6-amine;sulfuric acid;dihydrate Chemical compound O.O.OS(O)(=O)=O.NC1=NC=NC2=C1NC=N2.NC1=NC=NC2=C1NC=N2 MKPCNMXYTMQZBE-UHFFFAOYSA-N 0.000 description 7
- 235000013599 spices Nutrition 0.000 description 7
- 229960004039 finasteride Drugs 0.000 description 6
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 6
- 238000005342 ion exchange Methods 0.000 description 6
- 210000004761 scalp Anatomy 0.000 description 6
- 210000003780 hair follicle Anatomy 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 4
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 4
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 229920001213 Polysorbate 20 Polymers 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 229960005305 adenosine Drugs 0.000 description 4
- 150000003863 ammonium salts Chemical group 0.000 description 4
- -1 antiseptic Substances 0.000 description 4
- ILRSCQWREDREME-UHFFFAOYSA-N dodecanamide Chemical compound CCCCCCCCCCCC(N)=O ILRSCQWREDREME-UHFFFAOYSA-N 0.000 description 4
- 229940041616 menthol Drugs 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 4
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 4
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 4
- 230000008929 regeneration Effects 0.000 description 4
- 238000011069 regeneration method Methods 0.000 description 4
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- QZXSMBBFBXPQHI-UHFFFAOYSA-N N-(dodecanoyl)ethanolamine Chemical compound CCCCCCCCCCCC(=O)NCCO QZXSMBBFBXPQHI-UHFFFAOYSA-N 0.000 description 3
- 229960003473 androstanolone Drugs 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- VFKZECOCJCGZQK-UHFFFAOYSA-M 3-hydroxypropyl(trimethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)(C)CCCO VFKZECOCJCGZQK-UHFFFAOYSA-M 0.000 description 2
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 2
- DHHFDKNIEVKVKS-FMOSSLLZSA-N Betanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C\1C=C(C(O)=O)N[C@H](C(O)=O)C/1 DHHFDKNIEVKVKS-FMOSSLLZSA-N 0.000 description 2
- DHHFDKNIEVKVKS-MVUYWVKGSA-N Betanin Natural products O=C(O)[C@@H]1NC(C(=O)O)=C/C(=C\C=[N+]/2\[C@@H](C(=O)[O-])Cc3c\2cc(O)c(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)c3)/C1 DHHFDKNIEVKVKS-MVUYWVKGSA-N 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- OVBJJZOQPCKUOR-UHFFFAOYSA-L EDTA disodium salt dihydrate Chemical compound O.O.[Na+].[Na+].[O-]C(=O)C[NH+](CC([O-])=O)CC[NH+](CC([O-])=O)CC([O-])=O OVBJJZOQPCKUOR-UHFFFAOYSA-L 0.000 description 2
- 241001597008 Nomeidae Species 0.000 description 2
- 229920002690 Polyoxyl 40 HydrogenatedCastorOil Polymers 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 235000012677 beetroot red Nutrition 0.000 description 2
- 239000001654 beetroot red Substances 0.000 description 2
- 235000002185 betanin Nutrition 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 235000013877 carbamide Nutrition 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 229940068977 polysorbate 20 Drugs 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 2
- 229960003415 propylparaben Drugs 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- HNLXNOZHXNSSPN-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(OCCOCCOCCOCCOCCOCCOCCO)C=C1 HNLXNOZHXNSSPN-UHFFFAOYSA-N 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 102000004257 Potassium Channel Human genes 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000012930 cell culture fluid Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 229940031728 cocamidopropylamine oxide Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 230000003660 hair regeneration Effects 0.000 description 1
- 208000021245 head disease Diseases 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 150000002500 ions Chemical group 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- HLERILKGMXJNBU-UHFFFAOYSA-N norvaline betaine Chemical compound CCCC(C([O-])=O)[N+](C)(C)C HLERILKGMXJNBU-UHFFFAOYSA-N 0.000 description 1
- 229920004905 octoxynol-10 Polymers 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 108020001213 potassium channel Proteins 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229940107889 rogaine Drugs 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
成分 | %(w/w) |
第一阶段 | |
聚乙二醇-40氢化蓖麻油 | 0.5 |
聚山梨酸酯20(Tween-20) | 0.2 |
氚核X-100(Octoxynol 10) | 0.1 |
第二阶段 | |
腺嘌呤硫酸盐 | 0.02 |
薄荷醇 | 0.1 |
香料 | 0.2 |
离子交换水 | 98.8 |
成分 | %(w/w) |
羟基纤维素 | 1.0 |
乙二胺四乙酸二钠 | 0.1 |
柠檬酸钠 | 0.2 |
聚季铵盐7 | 2 |
月桂酰肌氨酸钠 | 10 |
月桂酰胺丙基甜菜碱 | 8 |
椰油酰胺丙基胺氧化物 | 6 |
月桂酰胺MEA | 6.2 |
尿素 | 0.3 |
尼泊金丙酯 | 0.2 |
腺嘌呤硫酸盐 | 0.05 |
薄荷醇 | 0.1 |
香料 | 0.2 |
离子交换水 | 65.55 |
成分 | %(w/w) |
聚季铵盐7 | 3.0 |
瓜尔胶羟丙基三甲基氯化铵 | 0.3 |
二甲基共聚醇 | 1.0 |
腺嘌呤硫酸盐 | 0.02 |
香料 | 0.5 |
离子交换水 | 95.2 |
样本8 | 样本9 | 控制组2 | |
成分 | %(w/w) | ||
第一阶段 | |||
聚乙二醇-40氢化蓖麻油 | 0.5 | 0.5 | 0.5 |
吐温-20(聚山梨醇酯20) | 0.1 | 0.1 | 0.1 |
第二阶段 | |||
腺嘌呤硫酸盐 | 0.1 | 0.05 | 0 |
香料 | 0.2 | 0.2 | 0.2 |
无热原水 | 99.0 | 99.05 | 99.1 |
Claims (9)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010105572969A CN102475633A (zh) | 2010-11-22 | 2010-11-22 | 毛发生长促进剂 |
CN201510534291.7A CN105106027B (zh) | 2010-11-22 | 2010-11-22 | 毛发生长促进剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010105572969A CN102475633A (zh) | 2010-11-22 | 2010-11-22 | 毛发生长促进剂 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510534291.7A Division CN105106027B (zh) | 2010-11-22 | 2010-11-22 | 毛发生长促进剂 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102475633A true CN102475633A (zh) | 2012-05-30 |
Family
ID=46088491
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510534291.7A Active CN105106027B (zh) | 2010-11-22 | 2010-11-22 | 毛发生长促进剂 |
CN2010105572969A Pending CN102475633A (zh) | 2010-11-22 | 2010-11-22 | 毛发生长促进剂 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510534291.7A Active CN105106027B (zh) | 2010-11-22 | 2010-11-22 | 毛发生长促进剂 |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN105106027B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103445971A (zh) * | 2012-05-31 | 2013-12-18 | 祥茂生活科技股份有限公司 | 促进毛发生长的组成物及方法 |
CN109908053A (zh) * | 2019-03-14 | 2019-06-21 | 广州德谷个人护理用品有限公司 | 一种滋润修复洗发乳液及其制备方法 |
CN110051595A (zh) * | 2019-03-14 | 2019-07-26 | 广州德谷个人护理用品有限公司 | 一种人参自然焗养丝滑洗发水及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1646078A (zh) * | 2002-04-09 | 2005-07-27 | 大塚制药株式会社 | 细胞增殖用组合物 |
CN1878530A (zh) * | 2003-11-11 | 2006-12-13 | 株式会社资生堂 | 用于毛发增粗的方法和组合物 |
WO2007074602A1 (ja) * | 2005-12-26 | 2007-07-05 | Lion Corporation | 頭皮毛髪化粧料 |
CN101217999A (zh) * | 2005-07-08 | 2008-07-09 | 宝洁公司 | 用于哺乳动物皮肤和毛发美化的个人护理组合物及方法 |
-
2010
- 2010-11-22 CN CN201510534291.7A patent/CN105106027B/zh active Active
- 2010-11-22 CN CN2010105572969A patent/CN102475633A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1646078A (zh) * | 2002-04-09 | 2005-07-27 | 大塚制药株式会社 | 细胞增殖用组合物 |
CN1878530A (zh) * | 2003-11-11 | 2006-12-13 | 株式会社资生堂 | 用于毛发增粗的方法和组合物 |
CN101217999A (zh) * | 2005-07-08 | 2008-07-09 | 宝洁公司 | 用于哺乳动物皮肤和毛发美化的个人护理组合物及方法 |
WO2007074602A1 (ja) * | 2005-12-26 | 2007-07-05 | Lion Corporation | 頭皮毛髪化粧料 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103445971A (zh) * | 2012-05-31 | 2013-12-18 | 祥茂生活科技股份有限公司 | 促进毛发生长的组成物及方法 |
CN109908053A (zh) * | 2019-03-14 | 2019-06-21 | 广州德谷个人护理用品有限公司 | 一种滋润修复洗发乳液及其制备方法 |
CN110051595A (zh) * | 2019-03-14 | 2019-07-26 | 广州德谷个人护理用品有限公司 | 一种人参自然焗养丝滑洗发水及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN105106027A (zh) | 2015-12-02 |
CN105106027B (zh) | 2018-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101291651B (zh) | 用于毛发生长的外用组合物 | |
JP4195763B2 (ja) | 毛髪保護作用と毛髪減損の予防性並びにアンドロゲン性脱毛症の外因作用とその結果もたらされる毛髪減損の低下性において、改善された性質を有するヘアローション | |
KR100238355B1 (ko) | 육모제 | |
CN108938485B (zh) | 一种防脱发的生发液及其制备方法 | |
CN103857379A (zh) | 毛发护理组合物及使用方法 | |
CN102716045A (zh) | 一种含有双去屑剂的香波组合物 | |
CN112823778A (zh) | 毛发护理组合物及其制备方法 | |
CN105555285A (zh) | 用于促进生发及毛发生长的组合物 | |
CN102475633A (zh) | 毛发生长促进剂 | |
US10987284B2 (en) | Volume boosting molding hair coloring creme formulation | |
CA2077850C (en) | Preparation for promoting hair growth | |
JP5902184B2 (ja) | 毛髪成長促進剤、睫毛と眉毛の成長促進剤、および脱毛防止剤 | |
TW202228757A (zh) | 育毛劑 | |
US9126056B2 (en) | Method of promoting hair growth | |
KR102021836B1 (ko) | 탈모증의 예방, 치료 또는 개선용 조성물 | |
KR101111094B1 (ko) | 탈모 방지 및 발모 제의 제조 방법 | |
JP3522388B2 (ja) | 発育毛剤 | |
JPH06183932A (ja) | 養毛化粧料 | |
US7622103B1 (en) | Hair and scalp toxin remover composition and method of its making | |
JP3496896B2 (ja) | 養毛剤及び毛髪用化粧料 | |
CN117257667A (zh) | 防脱固发的生发液及其制备方法 | |
EP2465581B1 (en) | Non-therapeutic use of a composition for promoting hair growth | |
JP3624318B2 (ja) | 養毛剤 | |
JPH1077216A (ja) | 養毛化粧料 | |
TW201143803A (en) | Hair growth promoting composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: ENERGENESIS BIOMEDICAL CO., LTD. Free format text: FORMER OWNER: CHEN HANMIN Effective date: 20150807 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20150807 Address after: Chinese Taiwan New Taipei City Applicant after: HUAAN MEDICAL CO., LTD. Address before: Taipei City, Taiwan Chinese big road a 157 Lane 12 Building No. 5 Applicant before: Chen Hanmin |
|
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20120530 |
|
RJ01 | Rejection of invention patent application after publication |